Incyte (INCY) - Revenue

Revenue in 2025 (TTM): HK$37.51 Billion

According to Incyte's latest financial reports the company's current revenue (TTM

) is HK$37.46 Billion. In 2024 the company made a revenue of HK$32.92 Billion an increase over the revenue in the year 2023 that were of HK$28.86 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2025

Annual revenue

Year	Revenue	Change
2025 (TTM)	HK$37.51 B	13.93%
2024	HK$32.92 B	14.08%
2023	HK$28.86 B	8.82%
2022	HK$26.52 B	13.9%
2021	HK$23.28 B	12.64%
2020	HK$20.67 B	22.96%
2019	HK$16.81 B	14.09%
2018	HK$14.73 B	22.78%
2017	HK$12.00 B	39.98%
2016	HK$8.57 B	46.77%
2015	HK$5.84 B	47.25%
2014	HK$3.96 B	44.14%
2013	HK$2.75 B	19.54%
2012	HK$2.30 B	213.86%
2011	HK$0.73 B	-44.51%
2010	HK$1.32 B	1740.27%
2009	HK$71.83 M	137.15%
2008	HK$30.29 M	-88.72%
2007	HK$0.26 B	24.9%
2006	HK$0.21 B	253.39%
2005	HK$60.84 M	-27.3%
2004	HK$83.68 M	-77.07%
2003	HK$0.36 B	-53.94%
2002	HK$0.79 B	-53.65%
2001	HK$1.70 B	12.9%
2000	HK$1.51 B	24.12%
1999	HK$1.22 B	16.82%
1998	HK$1.04 B	51.08%
1997	HK$0.69 B	117.45%
1996	HK$0.31 B

Revenue for similar companies or competitors

Company	Revenue	Revenue differencediff.	Country
Amgen AMGN	HK$280.01 B	647.36%	🇺🇸 USA
Ligand Pharmaceuticals LGND	HK$1.95 B	-94.78%	🇺🇸 USA
Eli Lilly LLY	HK$462.55 B	1,134.54%	🇺🇸 USA
Pfizer PFE	HK$488.76 B	1,204.48%	🇺🇸 USA
Geron GERN	HK$1.42 B	-96.19%	🇺🇸 USA
Ardelyx ARDX	HK$3.10 B	-91.73%	🇺🇸 USA
Novartis NVS	HK$438.83 B	1,071.22%	🇨🇭 Switzerland
AVEO Oncology AVEO	HK$0.73 B	-98.04%	🇺🇸 USA
CTI BioPharma CTIC	HK$0.58 B	-98.43%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Revenue for Incyte (INCY)

Revenue in 2025 (TTM): HK$37.51 Billion